Európska únia - slovenčina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. pozri časti 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Európska únia - slovenčina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastické činidlá - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

Európska únia - slovenčina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - antineoplastické činidlá - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).

Európska únia - slovenčina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - ostatné dermatologické prípravky - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Európska únia - slovenčina - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - prekurzorová bunková lymfoblastická leukémia-lymfóm - antineoplastické činidlá - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Európska únia - slovenčina - EMA (European Medicines Agency)

pacira limited - cytarabín - meningeálne nádory - antineoplastické činidlá - intravenózne liečenie lymfomatóznej meningitídy. u väčšiny pacientov bude takáto liečba súčasťou symptomatického zmiernenia ochorenia.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

becton dickinson infusion therapy systems inc. 9450 south state street sandy, utah spojené štáty americké -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

becton dickinson infusion therapy systems inc. 9450 south state street sandy, utah spojené štáty americké -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

becton dickinson infusion therapy ab (gasebäcksvägen 36) po box 631, florettgatan 29c helsingborg Švédsko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bausch & lomb inc. 1400 north goodman street 14609 rochester, ny spojené štáty americké -